Grading system for lymph vessel tumor emboli: significant outcome predictor for patients with invasive ductal carcinoma of the breast who received neoadjuvant therapy-Reference-Cited by-同舟云学术

Grading system for lymph vessel tumor emboli: significant outcome predictor for patients with invasive ductal carcinoma of the breast who received neoadjuvant therapy

Published:2010-01-29 Issue:4 Volume:23 Page:581-592
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Hasebe Takahiro,Tamura Nobuko,Iwasaki Motoki,Okada Nao,Akashi-Tanaka Sadako,Hojo Takashi,Shimizu Chikako,Adachi Masashi,Fujiwara Yasuhiro,Shibata Tatsuhiro,Sasajima Yuko,Tsuda Histoshi,Kinoshita Takayuki

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol20103.pdf

Reference26 articles.

1. Lauria R, Perrone F, Carlomagno C, et al. The prognostic value of lymphatic and blood vessel invasion in operable breast cancer. Cancer 1995;76:1772–1778.

2. Nime FA, Rosen PP, Tzvi Thaler H, et al. Prognostic significance of tumor emboli intramammary lymphatics in patients with mammary carcinoma. Am J Surg Pathol 1977;1:25–30.

3. Hasebe T, Sasaki S, Imoto S, et al. Characteristics of tumors in lymph vessels play an important role in the tumor progression of invasive ductal carcinoma of the breast: a prospective study. Mod Pathol 2002;15:904–913.

4. Hoshida T, Isaka N, Hagendoorn J, et al. Imaging steps of lymphatic metastasis reveals that vascular endothelilal growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. Cancer Res 2006;66:8065–8075.

5. Yamauchi C, Hasebe T, Iwasaki M, et al. Accurate assessment of lymph vessel tumor emboli in invasive ductal carcinoma of the breast according to tumor areas, and their prognostic significance. Hum Pathol 2007;38:247–259.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Residual pure intralymphatic carcinoma component only (lymphovascular tumor emboli without invasive carcinoma) after neoadjuvant chemotherapy is associated with poor outcome: Not pathologic complete response;Human Pathology;2024-03

2. Pathologic evaluation of specimens after neoadjuvant chemotherapy in breast cancer: Current recommendations and challenges;Pathology - Research and Practice;2022-02

3. Significance of prognostic indicators in infiltrating duct carcinoma breast: Scenario in developing country;Indian Journal of Cancer;2016

4. Lymph-Vascular Invasion;Diagnostic Pathology: Breast;2016

5. The role of EMT and MET in cancer dissemination;Connective Tissue Research;2015-08-20